Artificial Intelligence to Complement, Not Replace, Clinical Knowledge: Reading Between the Lines
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A
. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation. 1991; 83(1):162-9.
DOI: 10.1161/01.cir.83.1.162.
View
2.
Christopoulos G, Attia Z, Achenbach S, Rabe K, Call T, Ding W
. Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia. JACC CardioOncol. 2024; 6(2):251-263.
PMC: 11103028.
DOI: 10.1016/j.jaccao.2024.02.006.
View
3.
Burger J, Barr P, Robak T, Owen C, Ghia P, Tedeschi A
. Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study. Leukemia. 2019; 34(3):787-798.
PMC: 7214263.
DOI: 10.1038/s41375-019-0602-x.
View
4.
Brown J, Eichhorst B, Hillmen P, Jurczak W, Kazmierczak M, Lamanna N
. Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia. N Engl J Med. 2022; 388(4):319-332.
DOI: 10.1056/NEJMoa2211582.
View
5.
Quartermaine C, Ghazi S, Yasin A, Awan F, Fradley M, Wiczer T
. Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: State-of-the-Art Review. JACC CardioOncol. 2023; 5(5):570-590.
PMC: 10635896.
DOI: 10.1016/j.jaccao.2023.09.002.
View